当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析

中国医药

(600056)

  

流通市值:163.59亿  总市值:163.65亿
流通股本:14.95亿   总股本:14.96亿

中国医药(600056)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润3.75亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1412796.54万元,未分配利润779431.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产3671194.45万元,负债2258397.91万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入17,075,860,112.168,262,744,582.7534,148,359,638.9926,099,729,998.4
营业总成本16,438,279,511.827,973,445,487.2832,983,445,215.4225,216,783,611.99
其他经营收益
营业利润524,870,248.86304,650,879.12931,567,858.53850,564,674.59
利润总额520,722,428.39304,613,642.69953,188,513.89842,783,779
净利润375,327,120.46227,200,028.63686,623,882.02620,917,976.67
每股收益
其他综合收益2,628,805.36884,977.29-362,481.48-3,545,260.38
综合收益总额377,955,925.82228,085,005.92686,261,400.54617,372,716.29
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计27,822,270,967.0626,788,148,856.2927,414,324,032.928,878,917,996.98
非流动资产:
非流动资产合计8,889,673,571.338,902,906,995.768,911,001,979.378,998,958,623.37
资产总计36,711,944,538.3935,691,055,852.0536,325,326,012.2737,877,876,620.35
流动负债:
流动负债合计19,653,490,408.1217,223,758,138.3818,002,293,620.2419,912,131,853.43
非流动负债:
非流动负债合计2,930,488,687.734,127,982,443.793,993,465,112.133,876,990,851.76
负债合计22,583,979,095.8521,351,740,582.1721,995,758,732.3723,789,122,705.19
所有者权益(或股东权益):
归属于母公司股东权益合计11,723,575,812.9111,987,780,202.6112,032,631,883.3911,657,211,823.44
股东权益合计14,127,965,442.5414,339,315,269.8814,329,567,279.914,088,753,915.16
负债和股东权益合计36,711,944,538.3935,691,055,852.0536,325,326,012.2737,877,876,620.35
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计17,344,751,244.357,438,600,455.4236,243,984,709.6826,583,177,927.76
经营活动现金流出小计17,890,884,215.888,920,176,697.8435,238,554,160.0626,903,604,540.15
经营活动产生的现金流量净额-546,132,971.53-1,481,576,242.421,005,430,549.62-320,426,612.39
投资活动产生的现金流量:
投资活动现金流入小计27,549,739.828,187,430.1943,843,014.211,514,517.12
投资活动现金流出小计129,115,639.6865,496,987.21411,499,628.29281,151,821.22
投资活动产生的现金流量净额-101,565,899.86-57,309,557.02-367,656,614.08-279,637,304.1
筹资活动产生的现金流量:
筹资活动现金流入小计2,300,104,191.341,475,926,683.576,492,003,159.824,208,007,673.32
筹资活动现金流出小计3,025,074,766.631,429,227,227.676,750,237,069.634,581,509,564.69
筹资活动产生的现金流量净额-724,970,575.2946,699,455.9-258,233,909.81-373,501,891.37
汇率变动对现金及现金等价物的影响-1,024,669.09-842,648.331,779,865.311,887,281.63
现金及现金等价物净增加额-1,373,694,115.77-1,493,028,991.87381,319,891.04-971,678,526.23
期末现金及现金等价物余额2,483,455,574.72,218,549,837.943,711,578,829.812,358,580,412.54
补充资料:
现金及现金等价物的净增加额-1,373,694,115.77-381,319,891.04-
TOP↑